Jeff Schoenfeld, CEO of PAL Health Technologies, Inc., a privately held company headquartered in central Illinois, died at his Naples, Florida residence on November 28. He was 64 years old. Schoenfeld was a founding member, in 1974, of PAL Health Technologies.
Schoenfeld, PAL Health Technologies, Dies
1 min read Premium comments
Over the past 38 years, according to a company statement, Schoenfeld lead his firm in the development a comprehensive catalog of corrective foot devices including custom orthotics, diabetic and accommodative inserts and ankle braces. In the last decade, PAL developed XtremityOne, a digital foot imaging software system that allows for electronic storage of foot scans and ordering of custom foot orthoses.
“It was an honor and a privilege to work for Jeff for 30 years. The amount of guidance and dedication he had for PAL was phenomenal. He was a true leader and will be missed immensely, ” said Becky Hacker, a PAL employee since 1982. Memorial services are pending.
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.